Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CMS To Meet With NASPE/HRS, Manufacturers To Review ICD Decision Process

This article was originally published in The Gray Sheet

Executive Summary

Guidant maintains that its MADIT-II trial ethically could not have been extended to provide more evidence of the long-term benefits of ICDs for the entire study population

You may also be interested in...



SCD-HeFT Results Justify Expanded ICD Coverage – Medtronic’s Stanton

A CMS policy restricting ICD national coverage to a subgroup of the SCD-HeFT trial would undermine future clinical trial investment, according to Medtronic's Marshall Stanton, MD

SCD-HeFT Results Justify Expanded ICD Coverage – Medtronic’s Stanton

A CMS policy restricting ICD national coverage to a subgroup of the SCD-HeFT trial would undermine future clinical trial investment, according to Medtronic's Marshall Stanton, MD

Expanded ICD Patient Pool Augured By New Sub-Studies, Design Features

Cardiac rhythm management companies expect their investments in large randomized, controlled trials to spur increased adoption of ICDs this year

Related Content

UsernamePublicRestriction

Register

OM001644

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel